ADAD (Huaizhong Health Group) Debt-to-EBITDA : -1.61 (As of Jan. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADAD Huaizhong Health Group Inc ADAD
34 GF Score
Price $0.00
View Full Analysis

What is Huaizhong Health Group Debt-to-EBITDA?

Huaizhong Health Group ADAD 34 Debt-to-EBITDA is -1.61 as of Jan. 2023. GuruFocus rates ADAD with a GF Score™ of 34/100.

Debt-to-EBITDA measures a company's ability to pay off its debt.

Huaizhong Health Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2023 was $0.07 Mil. Huaizhong Health Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2023 was $0.00 Mil. Huaizhong Health Group's annualized EBITDA for the quarter that ended in Jan. 2023 was $-0.04 Mil. Huaizhong Health Group's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2023 was -1.61.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Huaizhong Health Group's Debt-to-EBITDA or its related term are showing as below:

ADAD's Debt-to-EBITDA is not ranked *
in the Diversified Financial Services industry.
Industry Median: 5.845
* Ranked among companies with meaningful Debt-to-EBITDA only.

Huaizhong Health Group  (OTCPK:ADAD) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Huaizhong Health Group Debt-to-EBITDA Related Terms

Huaizhong Health Group Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Huaizhong Health Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Huaizhong Health Group Debt-to-EBITDA Chart

Huaizhong Health Group Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.08 -0.25 -1.29 -2.45

Huaizhong Health Group Quarterly Data
Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.25 -2.46 -2.83 -2.54 -1.61

ADAD vs AMRR, NLSC, CLOW: Debt-to-EBITDA Comparison

For the Shell Companies subindustry, Huaizhong Health Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Huaizhong Health Group Debt-to-EBITDA vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Huaizhong Health Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Huaizhong Health Group's Debt-to-EBITDA falls into.


ADAD
34GF Score
Huaizhong Health Group Inc ADAD
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Huaizhong Health Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Huaizhong Health Group's Debt-to-EBITDA for the fiscal year that ended in Oct. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.071 + 0) / -0.029
=-2.45

Huaizhong Health Group's annualized Debt-to-EBITDA for the quarter that ended in Jan. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.071 + 0) / -0.044
=-1.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jan. 2023) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of -1.61 mean?
Huaizhong Health Group (ADAD) has a Debt-to-EBITDA of -1.61 as of Jan. 2023. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Huaizhong Health Group.
Is Huaizhong Health Group's Debt-to-EBITDA too high?
Huaizhong Health Group's current Debt-to-EBITDA is -1.61. Overall, Huaizhong Health Group has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Huaizhong Health Group's Debt-to-EBITDA compare to AMRR and NLSC?
Huaizhong Health Group's Debt-to-EBITDA of -1.61 can be compared against companies in the Diversified Financial Services industry. The industry median Debt-to-EBITDA is 5.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Diversified Financial Services company?
The median Debt-to-EBITDA among Diversified Financial Services companies is 5.85, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Huaizhong Health Group. For the Diversified Financial Services industry, the median Debt-to-EBITDA is 5.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Huaizhong Health Group's current Debt-to-EBITDA is -1.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huaizhong Health Group stock overvalued right now?
Huaizhong Health Group (ADAD) has a current Debt-to-EBITDA of -1.61. The current Debt-to-EBITDA is -1.61. Huaizhong Health Group's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Huaizhong Health Group (ADAD), the current Debt-to-EBITDA is -1.61 as of Jan. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Huaizhong Health Group Business Description

Address 555 Panyu North Avenue, 13th Floor, Headquarters Center Building 16, Tianan Technology Park, Panyu District, Guangzhou, CHN, 523857
Huaizhong Health Group Inc is a shell company. It is, however, seeking to identify, locate, and, if warranted, acquire new commercial opportunities.
34GF Score

Get the complete analysis for ADAD

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price